慢型乙型肝炎,Chronic hepatitis B
1)Chronic hepatitis B慢型乙型肝炎
2)Chronic hepatitis慢性乙型肝炎
1.Multicenter clinical study about the action of Fuz heng Huayu Capsule against liver fibrosis with chronic hepatitis B;扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床研究
2.The expression of P16 in hepatocellular carcinoma and chronic hepatitis;P16蛋白在原发性肝细胞肝癌及慢性乙型肝炎中表达情况探讨
3.Clinical research for treatment of chronic hepatitis with magnesium isoglycyrrhizinate;异甘草酸镁治疗慢性乙型肝炎的临床观察
英文短句/例句
1.The Clinical Study of the Therapy of Qingganfang for Chronic Hepatitis B;清肝方治疗慢性乙型肝炎的临床研究
2.The Clinical Study on Chronic Viral Hepatitis B Treated by YuGan Tabs;愈肝片治疗慢性乙型肝炎的临床研究
3.Hepatocyte Apoptosis in the Patients with Chronic Hepatitis B慢性乙型肝炎患者肝细胞凋亡的研究
4.Pathological analysis of liver tissues in 236 patients with chronic hepatitis B慢性乙型肝炎236例肝组织病理分析
5.Expression and clinical significance of HBsAg and HBcAg in hepatocytes in the patients with chronic hepatitis B慢性乙型肝炎肝组织HBsAg和HBcAg的表达
6.Clinical Research on Efficacy of Chronic Hepatitis B with Phyllanthus Compound Capsule;乙肝解毒胶囊治疗慢性乙型肝炎的临床研究
7.Clinical Trial of Zhuqi Yigan Pills for the Treatment of Chronic Hepatitis B珠芪乙肝丸治疗慢性乙型肝炎临床研究
8.Ployporus umbellatus polysaccharides combined with hepatitis B vaccine in treatiment of CHB in 128 cases猪苓多糖联合乙肝疫苗治疗慢性乙型肝炎128例
9.Research Progress of HBeAg-negative Chronic Hepatitis BHBeAg阴性慢性乙型肝炎研究进展
10.Treatment of Chronic Hepatitis B from Liver-Qi and Liver-Yang Deficiency从肝气虚与肝阳虚论治慢性乙型肝炎探讨
11.Clinical research of Baoganning against liver fibrosis after chronic hepatitis B保肝宁治疗慢性乙型肝炎肝纤维化的临床研究
12.Detection of HLA-DRB1 allele polymorphism of chronic hepatitis B patients with HBeAg negative河南汉族乙型肝炎e抗原阴性慢性乙型肝炎患者HLA-DRB1多态性检测
13.Objective: Observe the effect of Xiaozheng Kangxian (remove stasis and anti-fibrosis) Decoction (XZKXD) on the liver fibrosis of patients with chronic hepatitic (CH) Ⅱ.目的：观察消症抗纤汤对慢性乙型肝炎（慢乙肝）患者肝纤维化的疗效。
14.Hemorheologic Changes in Patients with Chronic Hepatitis B;慢性乙型肝炎患者血液流变学的研究
15.Study on Blood Stasis of Patients of Chronic Hepatitis B with Syndrome Dampness-heat Retention Spleen;慢性乙型肝炎湿热蕴脾证血瘀的研究
16.Discussion on the Methodology of both Diagnosis and Treatment of Chronic Hepatitis B;慢性乙型肝炎诊断和治疗方法学探讨
17.Look on the Antivirus Treatments in Patients with Chronic Hepatitis B Objectively;客观地看待慢性乙型肝炎抗病毒治疗
18.Expression of HBcAg in the Serum of Chronic Hepatitis B Patients慢性乙型肝炎患者血清HBcAg的状态研究
相关短句/例句
Chronic hepatitis慢性乙型肝炎
1.Multicenter clinical study about the action of Fuz heng Huayu Capsule against liver fibrosis with chronic hepatitis B;扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床研究
2.The expression of P16 in hepatocellular carcinoma and chronic hepatitis;P16蛋白在原发性肝细胞肝癌及慢性乙型肝炎中表达情况探讨
3.Clinical research for treatment of chronic hepatitis with magnesium isoglycyrrhizinate;异甘草酸镁治疗慢性乙型肝炎的临床观察
3)chronic hepatitis B慢性乙型肝炎
1.The relationship between HBV viral loads and liver damage severity in patients with HBeAg-negativechronic hepatitis B;HBeAg阴性慢性乙型肝炎病毒载量与肝损害的关系
2.Recent advance of telbivudine for the treatment ofchronic hepatitis B;替比夫定治疗慢性乙型肝炎的新进展
3.Study on efficacy of Adefovirdipivoxil therapy for patients withchronic hepatitis B resistant to Lamivudine;阿德福韦酯用于拉米夫定耐药慢性乙型肝炎的疗效研究
4)chronic type B hepatitis慢性乙型肝炎
1.Study of Lamivudine combined with Fuzheng-Fugan decoction onchronic type B hepatitis and effect on drug fast;拉米夫定联合扶正复肝方治疗慢性乙型肝炎及对拉米夫定耐药的影响研究
2.Curative Effect on Shrinking Spleen of Heluo Shugan Jiaonang ( Heluo Shugan Capsule) for Treatment of Chronic Type B Hepatitis;和络舒肝胶囊治疗慢性乙型肝炎缩脾疗效观察
3.Study of Adefovir onchronic type B hepatitis with Lamivudine resistance;阿德福韦治疗拉米夫定耐药慢性乙型肝炎的研究
5)Chronic B hepatitis慢性乙型肝炎
1.Observation of curative effects of oxymatrine combines with vaccae in the treatment of chronic B hepatitis;苦参素联合微卡治疗慢性乙型肝炎32例
2.To Evaluate the Regulation of Classical Differential Diagnosis of Traditional Chinese Medicine in Patients with Chronic B Hepatitis in Taiwan;台湾地区慢性乙型肝炎中医辨证论治规律探讨
3.Methods Serum hyaluronic acid (HA), laminin (LN) and type Ⅲ procollagen (PCⅢ) levels were measured with RIA in 40 patients with chronic B hepatitis treated with matrine and 40 other patients treated without matrine both before and 3, 6 months after treatment as well as in 32 controls.方法:用放射免疫分析测定了40例慢性乙型肝炎患者治疗前、治疗3、6个月2个治疗阶段血清透明质酸(HA)、层粘蛋白(LN)及Ⅲ型前胶原(PCⅢ)水平,并对测定结果与对照组和正常人组进行统计处理。
6)hepatitis B慢性乙型肝炎
1.Clinical evaluation of combination therapy of lamivudine and interferon α against chronichepatitis B;干扰素α联合拉米夫定治疗慢性乙型肝炎的疗效观察
2.Therapeutic Effect of Stronger Neo-minophagen C on Chronic Hepatitis B;复方甘草甜素注射液治疗慢性乙型肝炎疗效观察
3.Detection and significance of interlerkin 8 and interleukin 10 levels and HBVDNA in serums from patients with chronichepatitis B;慢性乙型肝炎患者血清HBVDNA含量与IL-8、IL-10水平检测及临床意义
延伸阅读
冻干人乙型肝炎免疫球蛋白【通用名称】冻干人乙型肝炎免疫球蛋白【其他名称】冻干人乙型肝炎免疫球蛋白 冻干人乙型肝炎免疫球蛋白 拼音名：Donggan Ren Yixingganyan Mianyi Qiudanbai 英文名：Lyophilized Human Hepatitis B Immunoglobulin 书页号：2000年版二部-1088 本品系用经乙型肝炎疫苗免疫的健康人血浆，经提取、灭活病毒、冻干制成。 【制法】照人乙型肝炎免疫球蛋白项下的方法制备，于灌装后及时冷冻干燥制成。 【性状】本品为白色或灰白色的疏松体。溶解后应为无色或淡黄色澄清液体，可带乳光，不应有 异物、浑 浊或摇不散的沉淀。 【鉴别】取本品，照《中国生物制品规程》进行。 (1)用免疫双扩散法测定，仅与抗人的血清产生沉淀线，与抗马、抗牛血清不应产生沉淀线。 (2)用免疫电泳法测定，主要沉淀线应为免疫球蛋白。 【检查】照《中国生物制品规程》规定的方法检查。除水分及溶解时间检查项外，应按规定加入 一定量灭 菌注射用水溶解后进行。 水分 不得过3.0％。 溶解时间 加入规定量的20～25℃灭菌注射用水后轻轻摇动，应在15分钟内完全溶解。 pH值 应为6.4～7.4。 蛋白质 不得过18.0％(g/ml)。 纯度 免疫球蛋白应不低于蛋白质总量的90.0％。 含糖量 如加入葡萄糖或麦芽糖，其含量不得过5.0％。 免疫球蛋白G单体及二聚体之和 应不低于90.0％。 HCV抗体 用国家批批检定合格的试剂盒检查，应为阴性。 HIV抗体 用国家批批检定合格的试剂盒检查，应为阴性。 异常毒性 取本品，依法检查，应符合规定。 热原 取本品，按家兔体重每1kg注射相当于0.15g免疫球蛋白，依法检查，应符合规定。 无菌 取本品，依法检查，应符合规定。 【效价测定】取本品，照《中国生物制品规程》规定的方法测定。每1ml含乙型肝炎抗体效价不得 低于 100国际单位。 【类别】血液制品。 【规格】(1)100国际单位 (2)200国际单位 (3)400国际单位 【贮藏与效期】在8℃以下的暗处保存。有效期5年。
